Search PDMR transactions

Notifier
Name of person with notification obligation
Stefan Nilsson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Stefan Nilsson
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Lipigon Pharmaceuticals AB
Issuer´s LEI code
549300XPO40YR12SLY87
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Lipigon Pharmaceuticals AB SE0015382072 Acquisition 342,315 Quantity 0.168655 SEK 02/12/2024 NASDAQ STOCKHOLM AB
Share Lipigon Pharmaceuticals AB SE0015382072 Acquisition 95,164 Quantity 0.1944 SEK 03/12/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Lipigon Pharmaceuticals AB SE0015382072 Acquisition 02/12/2024 NASDAQ STOCKHOLM AB 342,315 (Quantity) 0.168655 SEK
Lipigon Pharmaceuticals AB SE0015382072 Acquisition 03/12/2024 NASDAQ STOCKHOLM AB 95,164 (Quantity) 0.1944 SEK
Total: 437,479
<< Back